Clear Street’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.1K Buy
4,963
+2,994
+152% +$32K ﹤0.01% 958
2026
Q1
$20.8K Hold
1,969
﹤0.01% 885
2025
Q4
$20.7K Hold
1,969
﹤0.01% 717
2025
Q3
$20.4K Hold
1,969
﹤0.01% 625
2025
Q2
$20.2K Sell
1,969
-988
-33% -$10K ﹤0.01% 455
2025
Q1
$29.8K Buy
+2,957
New +$29.7K ﹤0.01% 247

Other funds holding TDAC

Clear Street's TDAC Position: Q2 2026 in Review

Clear Street increased its Translational Development Acquisition Corp (TDAC) stake by 152% in Q2 2026, buying an estimated $32K and bringing the position to 4,963 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Clear Street first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Clear Street held 4,963 shares of Translational Development Acquisition Corp worth $53.1K as of Q2 2026.
  • Clear Street bought 2,994 Translational Development Acquisition Corp shares in Q2 2026, an estimated $32K.
  • Translational Development Acquisition Corp made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #958 holding.
  • Clear Street first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.